Filip Krag Knop

Publikation

Publikationer pr. år 2003 2014 2016 2017 2018 2019 2019

• 224 Tidsskriftartikel
• 34 Review
• 17 Konferenceabstrakt i tidsskrift
• 13 Letter
• 13 Mere
  • 7 Kommentar/debat
  • 4 Konferenceartikel
  • 1 Bidrag til bog/antologi
  • 1 Poster

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2014

  Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1

  Sonne, D. P., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 okt. 2014, I: European Journal of Endocrinology. 171, 4, s. 407-419 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gallbladder Emptying 100%
  • Glucagon-Like Peptide 1 74%
  • Bile 62%
  • Type 2 Diabetes Mellitus 47%
  • Fats 47%
  36 Citationer (Scopus)

• Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease

  Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., jan. 2014, I: Nephrology, Dialysis, Transplantation. 29, 1, s. 119-27 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Pancreatic Hormones 100%
  • Incretins 86%
  • Chronic Kidney Failure 58%
  • Glucose 42%
  • Glucagon 34%
  11 Citationer (Scopus)

• Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial

  Idorn, T., Knop, F. K., Jorgensen, M. B., Jensen, T., Resuli, M., Hansen, P. M., Christensen, K. B., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., sep. 2014, I: Diabetologia. 57, 1 supplement, s. S370-S371 909.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

  1 Citationer (Scopus)

• Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): Implications for GLP-1 measurements in clinical studies

  Bak, M. J., Albrechtsen, N. J. W., Pedersen, J., Knop, F. K., Vilsbøll Lauritsen, T., Jørgensen, N. B., Hartmann, B., Deacon, C. F., Dragsted, L. O. & Holst, J. J., 1 nov. 2014, I: Diabetes, Obesity and Metabolism. 16, 11, s. 1155-1164 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Sensitivity and Specificity 63%
  • Clinical Studies 59%
  • Protein Isoforms 21%
  • Buffers 18%
  56 Citationer (Scopus)

• The authors reply

  Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., jan. 2014, I: Kidney International. 85, 1, s. 212-3 2 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

• The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus

  Christensen, M., Miossec, P., Larsen, B. D., Werner, U. & Knop, F. K., 1 okt. 2014, I: Expert Opinion on Drug Discovery. 9, 10, s. 1223-1251 29 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Lixisenatide 100%
  • lixisenatide 72%
  • Gastric Emptying 32%
  • Type 2 Diabetes Mellitus 32%
  • Insulin Derivative 29%
  18 Citationer (Scopus)

• The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

  Storgaard, H., Gluud, L. L., Christensen, M., Knop, F. K. & Vilsbøll, T., 2014, I: B M J Open. 4, 8, s. 1-5 5 s., e005378.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Sodium-Glucose Transporter 2 Inhibitors 100%
  • Symporters 94%
  • Type 2 Diabetes Mellitus 51%
  • Meta-Analysis 51%
  • Systematic Reviews 50%
  5 Citationer (Scopus)

• The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

  Rhee, N. A., Østoft, S. H., Holst, J. J., Deacon, C., Vilsbøll, T. & Knop, F. K., 1 sep. 2014, I: European Journal of Endocrinology. 171, 3, s. 353-362 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dipeptidyl Peptidase 4 100%
  • Incretins 96%
  • Psychological Inhibition 60%
  • Healthy Volunteers 49%
  • Glucose 46%
  19 Citationer (Scopus)

• The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract

  Rhee, N. A., Vilmann, P., Hassan, H., Hendel, J. W., Holst, J. J., Vilsbøll, T. & Knop, F. K., sep. 2014, I: Scandinavian Journal of Gastroenterology. 49, 9, s. 1143-1149 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Double-Balloon Enteroscopy 100%
  • Gastrointestinal Tract 55%
  • Type 2 Diabetes Mellitus 47%
  • Healthy Volunteers 42%
  • Biopsy 38%
  3 Citationer (Scopus)

• Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

  Knop, F. K., Lund, A., Madsbad, S., Holst, J. J., Krarup, T. & Vilsbøll, T., 31 maj 2014, I: BMC Research Notes. 7, s. 1-6 6 s., 326.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • C-Peptide 73%
  • Insulin Derivative 61%
  • Research Subjects 60%
  1 Citationer (Scopus)
• 2013

  Characterization of oral and intravenous glucose handling in truncally vagotomised subjects with pyloroplasty

  Plamboeck, A., Veedfald, S., Deacon, C., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C., Knop, F. K., Vilsbøll, T. & Holst, J. J., aug. 2013, I: European Journal of Endocrinology. 169, s. 187-201 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucose 100%
  • Glucagon-Like Peptide 1 82%
  • Glucose Tolerance Test 71%
  • Glucagon 55%
  • Incretins 45%
  42 Citationer (Scopus)

• Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies

  Rohde, U., Hedbäck, N., Gluud, L. L., Vilsbøll, T. & Knop, F. K., 2013, I: B M J Open. 3, 9, s. 1-5 e003417.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Type 2 Diabetes Mellitus 100%
  • Meta-Analysis 99%
  • Systematic Reviews 98%
  • Obesity 92%
  • Clinical Studies 92%
  14 Citationer (Scopus)

• Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

  Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., maj 2013, I: Kidney International. 83, 5, s. 915-23 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Chronic Kidney Failure 100%
  • Incretins 88%
  • Glucose 64%
  • Glucagon 35%
  • Hormones 24%
  22 Citationer (Scopus)

• GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

  Jespersen, M. J., Knop, F. K. & Christensen, M., jan. 2013, I: Expert Opinion on Drug Metabolism & Toxicology. 9, 1, s. 17-29 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor Agonist 100%
  • Glucagon-Like Peptide-1 Receptor 66%
  • Glucagon-Like Peptide 1 59%
  • Exenatide 55%
  • Toxicology 49%
  37 Citationer (Scopus)

• Gut microbiota may have influence on glucose and lipid metabolism.

  Mikkelsen, K. H., Nielsen, M. F., Tvede, M., Hansen, T., Pedersen, O. B., Holst, J. J., Vilsbøll, T. & Knop, F. K., 11 nov. 2013, I: Ugeskrift for Laeger. 175, 46, s. 2785-2788 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastrointestinal Microbiome 100%
  • Lipid Metabolism 97%
  • Glucose 63%
  • Fecal Microbiota Transplantation 48%
  • Obesity 47%
  1 Citationer (Scopus)

• Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

  Faurschou, A., Pedersen, J., Gyldenløve, M., Poulsen, S. S., Holst, J. J., Thyssen, J. P., Zachariae, C., Vilsbøll, T., Skov, L. & Knop, F. K., feb. 2013, I: Experimental Dermatology. 22, 2, s. 150-2 3 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Glucagon-Like Peptide-1 Receptor 81%
  • Psoriasis 62%
  • Agonist 60%
  • Skin 29%
  17 Citationer (Scopus)

• Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

  Faerch, K., Pilgaard, K., Knop, F. K., Hansen, T., Pedersen, O., Jørgensen, T. & Holst, J. J., jan. 2013, I: Diabetes, Obesity and Metabolism Online. 15, 1, s. 91-95 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T Cell Transcription Factor 1 100%
  • Pancreatic Hormones 95%
  • Incretins 82%
  • Alleles 46%
  • Glucose 39%
  18 Citationer (Scopus)

• Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

  Mari, A., Bagger, J. I., Ferrannini, E., Holst, J. J., Knop, F. K. & Vilsbøll, T., 3 sep. 2013, I: PLOS ONE. 8, 9, s. e73154

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • glucose tolerance 100%
  • Diabetes 99%
  • Glucose 98%
  • secretin 96%
  • Incretins 95%
  24 Citationer (Scopus)

• Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

  Sonne, D. P., Hare, K. J., Martens, P., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., 15 feb. 2013, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 304, 4, s. G413-9 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Gallbladder Emptying 67%
  • Hormones 60%
  • Glucose 53%
  • Glucagon-Like Peptide 2 44%
  24 Citationer (Scopus)

• Preserved postprandial GLP-1 and GIP responses in patients with maturity onset diabetes of the young

  Bagger, J. I., Ostoft, S. H., Hansen, T., Pedersen, O., Holst, J. J., Knop, F. K. & Vilsboll, T., 2013, I: Diabetologia. 56, s. S152-S152

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Psoriasis er associeret med type 2-diabetes

  Gyldenl�ve, M., Knop, F. K., Vilsb�ll, T., Zachariae, C. & Skov, L., 4 mar. 2013, I: Ugeskrift for Laeger. 175, 10, s. 652-4 3 s., 652.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  1 Citationer (Scopus)

• Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

  Bonde, L., Vilsbøll, T., Nielsen, T., Bagger, J. I., Svare, J. A., Holst, J. J., Larsen, S. & Knop, F. K., aug. 2013, I: Diabetes, Obesity and Metabolism. 15, 8, s. 713-720 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Gestational Diabetes 95%
  • Glucose 53%
  • Postpartum Period 27%
  • Pregnancy 22%
  24 Citationer (Scopus)

• Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study

  Idorn, T., Knop, F. K., Jørgensen, M., Jensen, T., Resuli, M., Hansen, P. M., Christensen, K. B., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., 26 apr. 2013, I: B M J Open. 3, 4, s. 1-10 11 s., e002764.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Liraglutide 100%
  • Chronic Kidney Failure 62%
  • Type 2 Diabetes Mellitus 53%
  • Research Personnel 49%
  • Placebos 49%
  11 Citationer (Scopus)

• Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

  Calanna, S., Christensen, M., Holst, J. J., Laferrère, B., Gluud, L. L., Vilsbøll, T. & Knop, F. K., maj 2013, I: Diabetologia. 56, 5, s. 965-72 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Area Under Curve 69%
  • Type 2 Diabetes Mellitus 64%
  • Meta-Analysis 63%
  • Systematic Reviews 62%
  155 Citationer (Scopus)

• Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

  Calanna, S., Christensen, M., Holst, J. J., Laferrère, B., Gluud, L. L., Vilsbøll, T. & Knop, F. K., okt. 2013, I: Diabetes Care. 36, 10, s. 3346-52 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Type 2 Diabetes Mellitus 100%
  • Meta-Analysis 99%
  • Systematic Reviews 98%
  • Clinical Studies 92%
  • Peptides 84%
  91 Citationer (Scopus)

• Sustained weight loss after treatment with a glucagon-like Peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes

  Ishøy, P. L., Knop, F. K., Lauritsen, T. V., Glenthøj, B. Y. & Ebdrup, B. H., 1 jun. 2013, I: American Journal of Psychiatry. 170, 6, s. 681-682 2 s.

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Formidling

  20 Citationer (Scopus)

• The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial

  Foghsgaard, S., Vedtofte, L., Mathiesen, E. R., Svare, J. A., Gluud, L. L., Holst, J. J., Damm, P., Knop, F. K. & Vilsbøll, T., 2013, I: B M J Open. 3, 10, s. 1-8 9 s., e003834.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Gestational Diabetes 86%
  • Research Personnel 53%
  • Placebos 53%
  • Glucose 48%
  6 Citationer (Scopus)

• The Effect of Exogenous GLP-1 on Food Intake is Lost in Male Truncally Vagotomized Subjects with Pyloroplasty

  Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendahl, C., Vilsboll, T., Knop, F. K. & Holst, J. J., 16 jun. 2013, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 304, s. G1117-G1127 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Eating 64%
  • Meals 22%
  • Gastric Emptying 19%
  • Glucagon 17%
  94 Citationer (Scopus)

• Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

  Knop, F. K., Konings, E., Timmers, S., Schrauwen, P., Holst, J. J. & Blaak, E. E., okt. 2013, I: Diabetic Medicine. 30, 10, s. 1214-1218 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Resveratrol 89%
  • Glucagon 80%
  • Hormones 54%
  • Glucagon-Like Peptide 1 33%
  40 Citationer (Scopus)
• 2012

  Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes

  Rhee, N. A., Vilsbøll, T. & Knop, F. K., apr. 2012, I: Diabetes, Obesity and Metabolism. 14, 4, s. 291-298

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Gastric Bypass 97%
  • Type 2 Diabetes Mellitus 64%
  • Incretins 15%
  • Hypoglycemic Agents 11%
  31 Citationer (Scopus)

• Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

  Vilsbøll, T., Christensen, M., Junker, A. E., Knop, F. K. & Gluud, C. N., 28 jan. 2012, I: B M J (Clinical Research Edition). 344, s. d7771

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Weight Loss 63%
  • Meta-Analysis 57%
  • Systematic Reviews 57%
  • Randomized Controlled Trials 52%
  566 Citationer (Scopus)

• Electroretinography in healthy subjects in relation to systemic glucocorticoid intake

  Kappelgaard, P., Hansen, K. B., Vilsbøll, T., Knop, F. K. & Larsen, M., feb. 2012, I: Documenta Ophthalmologica. 124, 1, s. 49-57 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Electroretinography 100%
  • Prednisolone 77%
  • Glucocorticoids 68%
  • Healthy Volunteers 50%
  • Hyperglycemia 19%
  3 Citationer (Scopus)

• Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

  Knop, F. K., Aaboe, K., Vilsbøll, T., Vølund, A., Holst, J. J., Krarup, T. & Madsbad, S., jun. 2012, I: Diabetes, Obesity and Metabolism. 14, 6, s. 500-510 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Fasting 61%
  • Type 2 Diabetes Mellitus 57%
  • Obesity 53%
  • Glucose 48%
  114 Citationer (Scopus)

• Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects

  Hansen, K. B., Vilsbøll, T., Bagger, J. I., Holst, J. J. & Knop, F. K., apr. 2012, I: Journal of Clinical Endocrinology and Metabolism. 97, 4, s. 1363-70 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Incretins 77%
  • Insulin Derivative 61%
  • Insulin Secretion 59%
  • Glucose 44%
  38 Citationer (Scopus)

• Increased levels of YKL-40 in patients with chronic pancreatitis and secondary diabetes

  Hansen, M., Nielsen, A. R., Vilsbøll, T., Lund, A., Krarup, T., Knop, F. K. & Vestergaard, H., 2012, I: Pancreas.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Incretin hormones in patients with type 2 diabetes are increased by diet-oil, a pro-drug for the GPR 119 receptor agonist, 2-oleoyl-glycerol

  Mandoe, M. J., Hansen, K. B., Knop, F. K., Holst, J. J. & Hansen, H. S., okt. 2012, I: Diabetologia. 55, s. S340-S340

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• The incretin effect in patients with maturity onset diabetes of the young

  Ostoft, S. H., Bagger, J. I., Hansen, T., Pedersen, O., Holst, J. J., Knop, F. & Vilsboll, T., 2012, I: Diabetologia. 55, s. S144-S144

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
• 2011

  2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

  Hansen, K. B., Rosenkilde, M. M., Knop, F. K., Wellner, N., Diep, T. A., Rehfeld, J. F., Andersen, U. B., Holst, J. J. & Hansen, H. S., sep. 2011, I: Journal of Clinical Endocrinology and Metabolism. 96, 9, s. E1409-17

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Protein Sorting Signals 68%
  • Glycerol 66%
  • G-Protein-Coupled Receptors 63%
  • Agonist 60%
  174 Citationer (Scopus)

• Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552-2554

  Knop, F. K., 1 apr. 2011, I: Diabetes Care. 34, 4, s. e44

  Publikation: Bidrag til tidsskrift › Letter › peer review

  1 Citationer (Scopus)

• Emerging GLP-1 receptor agonists

  Lund, A., Knop, F. K. & Vilsbøll, T., dec. 2011, I: Expert Opinion on Emerging Drugs. 16, 4, s. 607-18 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Glucagon-Like Peptide 1 34%
  • Type 2 Diabetes Mellitus 29%
  • Incretins 25%
  • Liraglutide 13%
  22 Citationer (Scopus)

• First case associating chronic pancreatitis and Ehlers-Danlos syndrome

  Hansen, K. B. & Knop, F. K., 2011, I: Pancreas. 40, 1

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

  Faurschou, A., Zachariae, C., Skov, L., Vilsbøll, T. & Knop, F. K., dec. 2011, I: Medical Hypotheses. 77, 6, s. 1098-1101

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Gastric Bypass 97%
  • Psoriasis 83%
  • Weight Loss 35%
  • Anti-Inflammatory Agents 15%
  24 Citationer (Scopus)

• Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding

  Usinger, L., Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, J. J. & Knop, F. K., maj 2011, I: Obesity Surgery. 21, 5, s. 625-32 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Gastric Emptying 88%
  • Stomach 55%
  • Hormones 54%
  • Glucose 48%
  24 Citationer (Scopus)

• Glucagon antagonism as a potential therapeutic target in type 2 diabetes

  Bagger, J. I., Knop, F. K., Holst, J. J. & Vilsbøll, T., nov. 2011, I: Diabetes, Obesity and Metabolism. 13, 11, s. 965-971 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon 100%
  • Type 2 Diabetes Mellitus 72%
  • Glucose 30%
  • Hyperglycemia 29%
  • Fasting 25%
  87 Citationer (Scopus)

• Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

  Christensen, M., Vedtofte, L., Holst, J. J., Vilsbøll, T. & Knop, F. K., dec. 2011, I: Diabetes. 60, 12, s. 3103-9 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon 100%
  • Insulin Secretion 95%
  • Peptides 61%
  • Glucose 60%
  • Hyperglycemia 38%
  181 Citationer (Scopus)

• Impaired regulation of the incretin effect in patients with type 2 diabetes

  Bagger, J. I., Knop, F. K., Lund, A., Vestergaard, H., Holst, J. J. & Vilsbøll, T., mar. 2011, I: Journal of Clinical Endocrinology and Metabolism. 96, 3, s. 737-45 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Type 2 Diabetes Mellitus 57%
  • Glucose 56%
  • Plasma 11%
  • Glycated Hemoglobin A 11%
  139 Citationer (Scopus)

• Increased Postprandial GIP and Glucagon Responses, But Unaltered GLP-1 Response after Intervention with Steroid Hormone, Relative Physical Inactivity, And High-Calorie Diet in Healthy Subjects

  Hansen, K. B., Vilsbøll, T., Bagger, J. I., Holst, J. J. & Knop, F. K., feb. 2011, I: Journal of Clinical Endocrinology and Metabolism. 96, 2, s. 447-53 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • Glucagon 80%
  • Steroid Hormone 76%
  • Sedentary Behavior 64%
  31 Citationer (Scopus)

• Inhibition de la sécrétion du glucagon par les antagonistes du GLP-1 et les inhibiteurs de la DPP-4

  Hansen, M., Knop, F. K. & Holst, J. J., apr. 2011, I: Medecine des Maladies Metaboliques. 5, 2

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Inhibition of glucagon secretion by GLP-1 agonists and DPP4 inhibitors

  Hansen, M., Juul Hare, K., Holst, J. J. & Knop, F. K., jun. 2011, I: Journal of Clinical Metabolism & Diabetes. 2, 2, s. 7-13 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dipeptidyl-Peptidase IV Inhibitors 100%
  • Glucagon-Like Peptide 1 88%
  • Glucagon 78%
  • Psychological Inhibition 61%
  • Incretins 49%

• Lixisenatide for type 2 diabetes mellitus

  Christensen, M., Knop, F. K., Vilsbøll, T. & Holst, J. J., apr. 2011, I: Expert Opinion on Investigational Drugs. 20, 4, s. 549-57 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • lixisenatide 100%
  • Glucagon-Like Peptide-1 Receptor 45%
  • Type 2 Diabetes Mellitus 44%
  • Long-Acting Insulin 17%
  • Metformin 12%
  68 Citationer (Scopus)